Press releases
- Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
- Revvity To Hold Earnings Call on Monday, April 29, 2024
- Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
- Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
- Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
- Revvity to Present at Upcoming Investor Conferences
- Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
- Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
More ▼
Key statistics
As of last trade, Revvity Inc (PKN:FRA) traded at 92.62, 21.07% above the 52 week low of 76.50 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 93.44 |
---|---|
High | 93.44 |
Low | 92.62 |
Bid | 92.96 |
Offer | 93.42 |
Previous close | 93.90 |
Average volume | 74.67 |
---|---|
Shares outstanding | 123.52m |
Free float | 123.18m |
P/E (TTM) | 69.79 |
Market cap | 12.42bn USD |
EPS (TTM) | 1.44 USD |
Annual div (ADY) | 0.2623 EUR |
---|---|
Annual div yield (ADY) | 0.30% |
Div ex-date | Apr 18 2024 |
Div pay-date | May 10 2024 |
Data delayed at least 15 minutes, as of Apr 18 2024 15:00 BST.
More ▼